Athena Diagnostics - Testing that Makes a Difference
Test Catalog
SearchBrowse

Enter symptom, disease type, test name or code


SearchBrowse

Use this pull down menu to view all tests offered within a disorder cateogy.

List of Patents

 
Test Code Test Name U.S. Patent No.
     
815 ABCD1 (Adrenoleukodystrophy) DNA Sequencing Test 5,644,045
     
     
871 BBS1 (BBS) DNA Sequencing Test 6,962,788
     
     
872 BBS2 (BBS) DNA Sequencing Test 7,008,782
     
     
827 ABCC8 (CH) DNA Sequencing Test 6,054,313
     
     
483 AChR/MuSK Reflexive Antibody Test 7,267,820
     
     
179 ADmark® Early Onset Alzheimer's Evaluation 6,194,153, 5,840,540
     
     
167 ADmark® PS-1 DNA Sequencing Test 6,194,153
     
     
169 ADmark® PS-2 DNA Sequencing Test 5,840,540
     
     
178 ADmark® Alzheimer's Evaluation 4,666,829, 5,593,846, 5,508,167, 5,861,257, 6,027,896, 5,843,779, 6,114,133, & 6,121,003
     
     
109 ADmark® ApoE Genotype Analysis & Interpretation (Symptomatic) 5,508,167, 6,027,896, & 5,716,828
     
     
177 ADmark® Phospho-Tau/Total-Tau/Ab42 CSF Analysis & Interpretation (Symptomatic) 4,666,829, 5,593,846, 5,861,257, 5,843,779, 6,114,133, & 6,121,003
     
     
166 ApoE Genotype Analysis 5,508,167, 6,027,896, & 5,716,828
     
     
493 Aprataxin DNA Sequencing Test 7,119,186
     
     
531 Atlastin (SPG3A) DNA Sequencing Test 7,108,975, 7,582,425, 7,649,088
     
     
743 Autism Spectrum Disorders Evaluation Pending
     
     
680 Autosomal Dominant Ataxia Evaluation 5,741,645, 5,834,183, 5,840,491, 5,853,995, 6,303,307, 6,280,938, 6,514,755, 6,524,791, 6,673,535, 6,844,431, 6,855,497, 7,118,893, 7,329,487, and 7,585,629
     
     
694 Autosomal Dominant Ataxia Evaluation 5,741,645, 5,834,183, 5,840,491, 5,853,995, 6,303,307, 6,280,938, 6,514,755, 6,524,791, 6,673,535, 6,844,431, 6,855,497, 7,118,893, 7,329,487, 7,585,629, and 7,655,401
     
     
651 Autosomal Dominant HSP Evaluation 7,108,975, 6,924,126, 7,582,425
     
     
825 Autosomal Dominant Hypocalcemia (ADH) Evaluation 5,688,938
     
     
652 Autosomal Recessive HSP Evaluation Pending
     
     
887 Bardet-Biedl Syndrome Evaluation 6,962,788; 7,008,782
     
     
244 Carpal Tunnel Syndrome Evaluation 5,306,616, 5,780,223, & 5,645,993
     
     
837 CEL (MODY8) Mutation Analysis 5,616,483; 5,827,683
     
     
347 Chronic Demyelinative Neuropathy Profile 5,306,616, 5,691,144, 5,645,993, 5,780,223, 6,001,576 & 6,599,756
     
     
741 CNTNAP2 DNA Sequencing Test Pending
     
     
277 Co-GM1 Quattro™ 5,989,829, 5,985,578, 6,824,999
     
     
861 COL1A1 (OI) DNA Sequencing Test 6,265,157
     
     
695 Complete Ataxia Evaluation 5,741,645, 5,834,183, 5,840,491, 5,853,995, 6,150,091, 6,303,307, 6,280,938, 6,514,755, 6,524,791, 6,844,431, 6,673,535, 6,855,497, 7,118,893, 7,119,186, 7,329,487, 7,527,931, 7,585,629, and 7,655,401
     
     
421 Complete CADASIL Evaluation 6,537,775, 6,995,257, 7,138,234
     
     
404 Complete CMT Evaluation 5,306,616, 5,691,144, 5,780,223, 5,645,993, 6,001,576, 5,876,927, 7,273,698
     
     
286 Complete Dejerine-Sottas Neuropathy Evaluation 5,876,927, 7,273,698
     
     
182 Complete DMD Evaluation - Females 5,621,091
     
     
181 Complete DMD Evaluation - Males 5,621,091
     
     
650 Complete Hereditary Spastic Paraplegia Evaluation 7,108,975, 6,924,126, 7,582,425
     
     
243 Complete HNPP Evaluation 5,306,616, 5,780,223, & 5,645,993
     
     
147 Complete Myotonia Evaluation 5,955,265; 5,977,333; 6,902,896
     
     
126 Complete Myotonic Dystrophy Evaluation 5,955,265 & 5,977,333
     
     
761 Complete PKD Evaluation 5,654,170, 6,031,088, 6,228,591, 6,485,960, 6,656,681, 6,916,619, 7,273,701, 7,294,465, 7,521,190, 7,553,644
     
     
153 Complete Rett Syndrome Evaluation 6,709,817 and 7,670,773
     
     
573 Complete SCN1A Evaluation 7,078, 515
     
     
556 Complete Tuberous Sclerosis Evaluation 6,207,374, 6,232,452, 6,326,483 and 6,548,258
     
     
819 Congenital Hyperinsulinism Evaluation 6,054,313
     
     
245 Congenital Hypomyelination Evaluation 5,876,927
     
     
321 Connexin 26 DNA Sequencing Test 5,998,147, 6,485,908, 7,258,975
     
     
329 Connexin Related Deafness Evaluation 5,998,147, 6,485,908, 7,258,975
     
     
133 Connexin32 DNA Sequencing Test 5,691,144 & 6,001,576
     
     
143 Connexin32 Evaluation 5,691,144 & 6,001,576
     
     
108 DM1 DNA Test 5,955,265 & 5,977,333
     
     
110 DM2 DNA Test 6,902,896
     
     
414 Dominant CMT Evaluation 5,306,616, 5,691,144, 5,780,223, 5,645,993, 6,001,576, & 5,876,927
     
     
561 Dysferlin Blood Test 7,172,858
     
     
626 Dystonia (DYT1) DNA Test 6,387,616
     
     
100 Dystrophin Test 5,541,074, 5,621,091, 5,239,060
     
     
207 Early Onset Myotonia Evaluation 5,955,265; 5,977,333
     
     
640 Early Onset Obesity (MC4R) Evaluation 5,622,860, 5,703,220
     
     
881 Endocrine Hypertension (HSD11B2) Evaluation 5,883,240
     
     
296 Entrapment Neuropathy Evaluation 5,306,616, 5,780,223, & 5,645,993
     
     
410 EPM1 DNA Test 6,432,635
     
     
411 EPM2A DNA Test 6,825,328
     
     
187 Familial Hemiplegic Migraine Type I DNA Test 5,714,319
     
     
829 Familial Hypocalciuric Hypercalcemia (CASR) Evaluation 5,688,938
     
     
104 Fragile X DNA Test 5,658,764
     
     
119 Friedreich Ataxia DNA Test 6,150,091
     
     
261 GALOP™ Antibody Test 6,121,004
     
     
803 GCK (MODY2) DNA Sequencing and DeletionTest 5,541,060
     
     
190 Hemiplegic Migraine Evaluation 5,714,319
     
     
802 HNF4A (MODY1) DNA Sequencing and Deletion Test 6,187,533
     
     
715 Inherited Focal and Segmental Glomerulosclerosis (FSGS) Evaluation 6,924,110 and 7,388,086
     
     
834 IPF1 (MODY4) DNA Sequencing Test 6,274,310
     
     
841 IPF1 (NDM) DNA Sequencing Test 6,274,310
     
     
545 KCNQ2 DNA Sequencing Test 6,413,719, 7,214,483
     
     
415 Lafora Disease Evaluation 6,825,328
     
     
222 LITAF/SIMPLE DNA Sequencing Test 7,449,291
     
     
811 LRP5 (OPPG) DNA Sequencing Test 6,555,654 & 6,545,137
     
     
821 LRP5 Idiopathic Osteoporosis (IOP) DNA Sequencing Test 6,555,654, 6,545,137
     
     
145 MAG 'Dual Antigen'® Antibody Test 6,599,756, 6,951,763
     
     
817 Male Precocious Puberty (LHCGR) Evaluation 6,635,445
     
     
850 Monogenic Diabetes (MODY) Evaluation 6,187,533, 5,541,060, 6,274,310
     
     
288 Motor Neuropathy Profile-Complete 5,443,952, 5,603,934, 5,807,705, 5,989,829, 5,985,578, 6,020,140, 6,121,004 & 6,599,756
     
     
259 Motor Neuropathy Profile-Standard 5,989,829, 5,985,578, 6,077,681 & 6,599,756
     
     
289 Multifocal Neuropathy Evaluation 5,989,829 & 5,985,578
     
     
470 MuSK Antibody Test 7,267,820
     
     
482 MuSK Quantitative Titers Antibody Test 7,267,820
     
     
134 Myelin Protein Zero (MPZ) DNA Sequencing Test 5,876,927
     
     
418 Myoclonus Epilepsy Evaluation 6,432,635, 6,825,328
     
     
431 NeoCerebellar Degeneration Paraneoplastic Profile with Recombx™ 5,603,934, 5,807,705, 5,668,013, 5,925,526, 6,193,948, 6,387,639, 7,026,450, and 7,329,499
     
     
429 NeoComplete Paraneoplastic Profile with Recombx™ 5,603,934, 5,614,371, 5,668,013, 5,786,451, 5,807,705 5,925,526, 6,387,639, and 7,329,499
     
     
432 NeoEncephalitis Paraneoplastic Profile with Recombx™ 5,603,934, 5,807,705, 6,193,948, 6,387,639, 7,026,450, and 7,329,499
     
     
882 Neonatal Diabetes Mellitus Evaluation 6,274,310
     
     
365 NeoPLAST® Basic Paraneoplastic Profile 5,603,934, 5,614,371, 5,668,013, 5,786,451, 5,807,705 & 5,925,526
     
     
360 NeoSeM® Basic Paraneoplastic Profile 5,603,934, 5,807,705, 5,668,013, 5,925,526, & 6,193,948
     
     
436 NeoSensory Neuropathy Paraneoplastic Profile with Recombx™ 5,603,934, 5,807,705, 6,193,948 and 7,329,499
     
     
721 Nephrotic Syndrome Evaluation 6,207,811, 6,924,110, 7,105,291 and 7,388,086
     
     
730 NPHS1 (Nephrin) Sequencing Analysis 6,207,811 and 7,105,291
     
     
710 NPHS2 (Podocin) Sequencing Analysis 6,924,110 and 7,388,086
     
     
300 OPMD DNA Test 6,828,430
     
     
860 Osteogenesis Imperfecta Evaluation 6,265,157
     
     
327 OtoDx™ Aminoglycoside Hypersensitivity Test 5,506,101
     
     
407 Partial CMT Evaluation - Demyelinating Only 5,306,616, 5,691,144, 5,780,223, 5,645,993, & 6,001,576
     
     
406 Partial CMT Evaluation - Recessive Only 7,273,698
     
     
409 Partial CMT Evaluation - Recessive Only 7,273,698
     
     
413 Partial CMT- Axonal Only 5,645,993, 5,691,144, 6,001,576, & 5,876,927
     
     
103 Partial DMD - del/dup only - Females 5,621,091
     
     
101 Partial DMD - del/dup only - Males 5,621,091
     
     
183 Partial DMD - Sequencing only 5,621,091
     
     
239 Periaxin DNA Sequencing Test 7,273,698
     
     
728 PKDx® Familial Mutation Evaluation 5,654,170, 6,031,088, 6,228,591, 6,485,960, 6,656,681, 6,916,619, 7,273,701, 7,294,465
     
     
725 PKDx® Sequencing Analysis 5,654,170, 6,031,088, 6,228,591, 6,485,960, 6,656,681, 6,916,619, 7,273,701, 7,294,465, 7,521,190, 7,553,644
     
     
131 PMP22 Duplication/Deletion DNA Test 5,306,616, 5,780,223, 5,645,993, & 5,599,920
     
     
118 Recombx™ CAR (Anti-Recoverin) Antibody Test 5,786,451
     
     
122 Recombx™ MaTa Antibody Test 6,387,639; 7,026,450
     
     
123 Recombx™ CV2 Antibody Test 7,183,400 and 7,329,499
     
     
120 Recombx™ Hu Antibody Test 5,603,934 & 5,807,705
     
     
115 Recombx™ Ri Antibody Test 5,614,371
     
     
125 Recombx™ Yo Antibody Test 5,668,013 & 5,925,526
     
     
142 Rett Syndrome (MECP2) DNA Sequencing Test 6,709,817, 7,670,773
     
     
148 Rett Syndrome (MECP2) Duplication/Deletion Analysis 6,709,817, 7,670,773
     
     
371 SCA1 DNA Test 5,741,645, & 5,834,183
     
     
284 SCA13 Select Exon DNA Test 7,585,629
     
     
593 SCA14 DNA Test 7,655,401
     
     
372 SCA2 DNA Test 6,673,535, 6,844,431
     
     
105 SCA3 (Machado-Joseph Disease) DNA Test 5,840,491
     
     
389 SCA5 Select Exon DNA Test 7,527,931
     
     
373 SCA6 DNA Test 5,853,995, 6,303,307, 7,329,487
     
     
374 SCA7 DNA Test 6,280,938, 6,514,755, 7,118,893
     
     
384 SCA8 DNA Test 6,524,791
     
     
535 SCN1A DNA Sequencing Test 7,078, 515
     
     
264 SensoriMotor Neuropathy Profile 5,443,952, 6,020,140, 5,603,934, 5,807,705 & 6,599,756
     
     
287 SensoriMotor Neuropathy Profile-Complete 5,443,952, 5,603,934, 5,807,705, 5,989,829, 5,985,578, 6,020,140, 6,121,004 & 6,599,756
     
     
265 Sensory Neuropathy Profile 5,603,934, 5,807,705, 5,443,952, 6,020,140, 6,193,948 & 6,599,756
     
     
263 Sensory Neuropathy Profile-xp 5,603,934, 5,807,705, 5,443,952, 6,020,140, 6,121,004, 6,193,948 & 6,599,756
     
     
742 SHANK3 DNA Sequencing Test Pending
     
     
448 SMA Carrier Plus (Reflexive) 6,080,577; 7,033,752
     
     
234 Small Fiber Painful Axonal Neuropathy Profile 5,443,952, 5,807,705, 5,603,934 & 6,020,140
     
     
530 Spastin (SPG4) DNA Sequencing Test 6,924,126
     
     
633 Spatacsin (SPG11) DNA Sequencing Test Pending
     
     
111C Spinal Muscular Atrophy Carrier Test 6,080,577; 7,033,752
     
     
444 Spinal Muscular Atrophy Carrier Test 6,080,577; 7,033,752
     
     
111D Spinal Muscular Atrophy Diagnostic Test 6,080,577; 7,033,752
     
     
210 Sulfatide Antibody Test 5,443,952, 6,020,140
     
     
804 TCF1 (MODY3) DNA Sequencing and Deletion Test 6,187,533
     
     
805 TCF2 (MODY5) DNA Sequencing and Deletion Test 6,187,533
     
     
523 TSC Familial Mutation Evaluation 6,207,374, 6,232,452
     
     
521 TSC1 DNA Sequencing Test 6,326,483 and 6,548,258
     
     
524 TSC2 DNA Deletion Test 6,207,374, 6,232,452
     
     
522 TSC2 DNA Sequencing Test 6,207,374, 6,232,452
     
     
Canada US